by FiveSenses | Oct 18, 2023 | News Release
Vancouver, BC, Canada, October 17th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that the... 
by FiveSenses | Oct 17, 2023 | News Release
Vancouver, BC, Canada, October 17th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that... 
by FiveSenses | Oct 11, 2023 | Communiqué de presse
Vancouver, C.-B. Canada, 6 octobre 2023 – Defence Therapeutics Inc. (« Defence » ou la « Société »), une entreprise biopharmaceutique spécialisée dans le développement de vaccins et de technologies d’administration de médicaments immuno-oncologiques, a le plaisir... 
by FiveSenses | Oct 11, 2023 | News Release
Vancouver, BC, Canada, October 6th 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce its... by FiveSenses | Oct 10, 2023 | News Release
Vancouver, BC, Canada, October 10th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a biotechnology company developing various products for the immune-oncology vaccines and drug delivery technologies, is pleased to announce the publication of a...
Recent Comments